Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7039294

NCCCC[C@@](N)(C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)c3ccccc3O)cc2)c2ccc(NC(=O)[C@](N)(CCCCN)C(=O)c3ccccc3O)cc2)cc1)C(=O)c1ccccc1O.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLK1 P06870 2/20 0.39
KLK5 Q9Y337 2/20 0.39
LMNA P02545 3/20 0.34
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 2/20 0.34
HTT P42858 2/20 0.34
HPGD P15428 2/20 0.34
POLB P06746 1/20 0.34
PNLIP P16233 1/20 0.32
MAPT P10636 1/20 0.32
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PLAU P00749 2/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6290918 0.89 MLYCD (0.37) KLK1KLK5LMNAHSD17B10MEN1
Trifluoroacetic Acid SCHEMBL6287794 0.89 MLYCD (0.37) KLK1KLK5LMNAHSD17B10MEN1
SCHEMBL6287743 0.88 KDM4E (0.31) KLK1KLK5LMNAKDM4EHSD17B10
Trifluoroacetic Acid SCHEMBL6286326 0.88 NR1H4 (0.37) KLK1KLK5MEN1KMT2ACA12
Trifluoroacetic Acid SCHEMBL7038495 0.83 TP53 (0.35) KLK1KLK5KDM4ETP53HTT
Trifluoroacetic Acid SCHEMBL6287884 0.83 KEAP1 (0.37) KLK1KLK5KDM4EMEN1KMT2A
Trifluoroacetic Acid SCHEMBL7039259 0.83 GABRB1 (0.40) MEN1KMT2APOLBF2F10
Trifluoroacetic Acid SCHEMBL6288018 0.82 CES1 (0.39) LMNATP53POLBMAPTCA12
Trifluoroacetic Acid SCHEMBL6286281 0.82 CES1 (0.39) LMNATP53POLBMAPTCA12
SCHEMBL6287650 0.77 CA1 (0.43) LMNAMAPTCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK KLK1 2324/4885KLK5 3413/4885LMNA 3699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.